Evidence map›Paper›PMID 31536360›Full record

ArticleNano letters2020

Electrochemical Detection of Tumor-Derived Extracellular Vesicles on Nanointerdigitated Electrodes.

Dilu G Mathew, Pepijn Beekman, Serge G Lemay, Han Zuilhof, Séverine Le Gac, Wilfred G van der Wiel

Open access · hybridAbstract read
In one paragraph

Article in Nano letters, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed, 1 pooled it
4.3field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 1 synthesis or guideline pooled it, 92 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. Development of surface-functionalized power-free microchip for breast cancer cell-derived extracellular vesicle detection.Analytical sciences : the international journal of the Japan Society for Analytical Chemistry · 2026
    Article
  5. Review
  6. Review
  7. Review
  8. Article
  9. Review
  10. Review
  11. Article
  12. Review
  13. Review
  14. Article
  15. Review
  16. Review
  17. Review
  18. Review
  19. Article
  20. Liquid Biopsies: Flowing Biomarkers.Advances in experimental medicine and biology · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 3 countries.

Dilu G MathewNanoElectronics Group, MESA+ Institute for Nanotechnology , University of Twente , P.O. Box 217, Enschede , 7500 AE The Netherlands.
Pepijn BeekmanLaboratory for Organic Chemistry , Wageningen University , Stippeneng 4 , Wageningen , 6708WE The Netherlands.ORCID 0000-0001-8401-9777
Serge G LemayBioelectronics, MESA+ Institute for Nanotechnology , University of Twente , P.O. Box 217, Enschede , 7500 AE The Netherlands.ORCID 0000-0002-0404-3169
Han ZuilhofLaboratory for Organic Chemistry , Wageningen University , Stippeneng 4 , Wageningen , 6708WE The Netherlands.
Séverine Le GacApplied Microfluidics for BioEngineering Research, MESA+ Institute for Nanotechnology, TechMed Center , University of Twente , P.O. Box 217, Enschede , 7500 AE The Netherlands.
Wilfred G van der WielNanoElectronics Group, MESA+ Institute for Nanotechnology , University of Twente , P.O. Box 217, Enschede , 7500 AE The Netherlands.ORCID 0000-0002-3479-8853
University of Twente · NLTianjin University · CNWageningen University & Research · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Tumor-derived extracellular vesicles (tdEVs) are attracting much attention due to their essential function in intercellular communication and their potential as cancer biomarkers. Although tdEVs are significantly more abundant in blood than other cancer biomarkers, their concentration compared to other blood components remains relatively low. Moreover, the presence of particles in blood with a similar size as that of tdEVs makes their selective and sensitive detection further challenging. Therefore, highly sensitive and specific biosensors are required for unambiguous tdEV detection in complex biological environments, especially for decentralized point-of-care analysis. Here, we report an electrochemical sensing scheme for tdEV detection, with two-level selectivity provided by a sandwich immunoassay and two-level amplification through the combination of an enzymatic assay and redox cycling on nanointerdigitated electrodes to respectively enhance the specificity and sensitivity of the assay. Analysis of prostate cancer cell line tdEV samples at various concentrations revealed an estimated limit of detection for our assay as low as 5 tdEVs/μL, as well as an excellent linear sensor response spreading over 6 orders of magnitude (10-10

Indexed as

Biosensing TechniquesBiomarkers, TumorElectrochemical TechniquesElectrodesExtracellular VesiclesHumansImmunoassayLimit of DetectionNeoplasmsBiomarkers, Tumorenzymatic amplificationmicrofluidicsNanoelectrodesredox cyclingtumor-derived extracellular vesicles

Identifiers

PMID31536360
PMCPMC7020140
OpenAlexW2974684811

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.